Cargando…

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis

OBJECTIVE: To investigate the efficacy of minodronate in the treatment of glucocorticoid-induced osteoporosis (GIO). METHODS: The study population included patients in whom the administration of minodronate (50 mg, once every 4 weeks) had been newly started for the treatment of GIO in Niigata Rheuma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasegawa, Eriko, Ito, Satoshi, Takai, Chinatsu, Kobayashi, Daisuke, Nomura, Yumi, Otani, Hiroshi, Abe, Asami, Ishikawa, Hajime, Murasawa, Akira, Narita, Ichiei, Nakazono, Kiyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120818/ https://www.ncbi.nlm.nih.gov/pubmed/29607978 http://dx.doi.org/10.2169/internalmedicine.9885-17

Ejemplares similares

An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2018)

The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
por: Hasegawa, Eriko, et al.
Publicado: (2023)

Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis
por: Kurosawa, Yoichi, et al.
Publicado: (2022)

Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis
por: Nemoto, Tetsuya, et al.
Publicado: (2020)

Erratum for Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis
por: Nemoto, Tetsuya, et al.
Publicado: (2021)

Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
por: Takai, Chinatsu, et al.
Publicado: (2020)

Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
por: Takai, Chinatsu, et al.
Publicado: (2021)

The Combination of Modified Mitchell’s Osteotomy and Shortening Oblique Osteotomy for Patients with Rheumatoid Arthritis: An Analysis of Changes in Plantar Pressure Distribution
por: Lee, Hyunho, et al.
Publicado: (2021)

Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report
por: Sato, Hiroe, et al.
Publicado: (2014)

Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis
por: Sato, Hiroe, et al.
Publicado: (2020)

An Analysis of the Neuropathic Pain Components in Rheumatoid Arthritis Patients
por: Ito, Satoshi, et al.
Publicado: (2017)

Minodronate for the treatment of osteoporosis
por: Ohishi, Tsuyoshi, et al.
Publicado: (2018)

Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis
por: Kobayashi, Tetsuo, et al.
Publicado: (2016)

Interleukin‐6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors
por: Kobayashi, Tetsuo, et al.
Publicado: (2015)

Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis
por: Okazaki, R., et al.
Publicado: (2011)

Three years of treatment with minodronate in patients with postmenopausal osteoporosis
por: Hagino, Hiroshi, et al.
Publicado: (2011)

A review of minodronic acid hydrate for the treatment of osteoporosis
por: Tanishima, Shinji, et al.
Publicado: (2013)

Minodronate in the treatment of osteoporosis: A systematic review and meta-analysis
por: Liu, Qingshan, et al.
Publicado: (2020)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials
por: Hirota, Masashi, et al.
Publicado: (2021)

The effects of minodronate and activated vitamin D on bone mineral density and muscle mass in postmenopausal women with osteoporosis
por: Fujimoto, Kazuki, et al.
Publicado: (2018)

Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene
por: Ohta, Hiroaki, et al.
Publicado: (2023)

Effects of monthly minodronate with or without eldecalcitol addition in osteoporosis patients with rheumatoid arthritis: An 18-month prospective study
por: Suzuki, Takako, et al.
Publicado: (2019)

Circulating levels of carbamylated protein and neutrophil extracellular traps are associated with periodontitis severity in patients with rheumatoid arthritis: A pilot case-control study
por: Kaneko, Chihiro, et al.
Publicado: (2018)

Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats
por: Yano, Tetsuo, et al.
Publicado: (2021)

Influence on the bone mineral density and bone metabolism marker after the interruption and reinitiation of monthly minodronate therapy in postmenopausal women with osteoporosis
por: Okimoto, Nobukazu, et al.
Publicado: (2018)

Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
por: Tanaka, Mizue, et al.
Publicado: (2017)

Drug-induced hypersensitivity syndrome caused by minodronic acid hydrate
por: Muto, Yutaka, et al.
Publicado: (2021)

Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports
por: Kobayashi, Tetsuo, et al.
Publicado: (2019)

A Case of Podocytic Infolding Glomerulopathy with Focal Segmental Glomerulosclerosis
por: Iguchi, Akira, et al.
Publicado: (2013)

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study
por: Matsumoto, T., et al.
Publicado: (2008)

Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction
por: Saeki, Takako, et al.
Publicado: (2015)

Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)

Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

False‐positive semiquantitative immunochromatography assays for procalcitonin in three patients with rheumatoid arthritis—A case series
por: Sato, Hiroe, et al.
Publicado: (2020)

The Assessment of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Glucocorticoid-induced Diabetes by Continuous Glucose Monitoring
por: Yata, Yusuke, et al.
Publicado: (2017)

Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
por: Kamimura, Mikio, et al.
Publicado: (2016)

Effect of organic solvents on calcium minodronate crystal morphology in aqueous solution: an experimental and theoretical study
por: Zhuang, Chen, et al.
Publicado: (2023)

Advances in Glucocorticoid-Induced Osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j0afn9tmh6tdk5drgvhcjjs99k